Video
4 Dec 2024

Sanner end-to-end CDMO services

MP4 80.5 MB
Watch Video

We operate with substantial production capacity, agility and scalability that enables us to support companies to bring medical devices to market efficiently and effectively. As a CDMO, we provide a full spectrum of services, from the initial design and development phases to mass production of everything from simple, single-use consumables to complex electromechanical devices.
 

Content provided by our supplier

Sanner Group

  • DE
  • 2015
    On CPHI since
  • 3
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Packaging supplier/manufacturer
View company profile

Other Content from Sanner Group (2)

  • News Sanner at Pharmapack: new developments and capacity expansions

    At Pharmapack in Paris, Sanner will provide first insights into the new developments planned for 2025. These include desiccant and effervescent tablet packaging as well as the expansion of the CDMO portfolio for medical devices.
    4 Dec 2024
  • Sanner Academy

    Technical Data Sanner Academy

    On the Sanner Academy Platform our experts share specific information about products, use of desiccants, new innovations, development expertise, sustainability, new trends and much more. https://www.sanner-group.com/en/sanner-academy

    Webinars: In the Sanner webinars we give background information on products, services and development issues. For each webinar there is at least an English version for our international customer basis, for some there might be a German version as well.

    Podcast & Whitepaper: Here you can find podcasts in English and German on trending topics like e.g. sustainable packaging as well as whitepapers on specific scientific research done by Sanner with more background information in English, German and French.

    Product Insights: Here you will find short clips or videos presenting information about the Sanner  Product Portfolio or new Product Solutions.